156 related articles for article (PubMed ID: 15258185)
1. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
[TBL] [Abstract][Full Text] [Related]
3. The angiotensin receptor blocker, azilsartan medoxomil (TAK-491), suppresses vascular wall expression of plasminogen activator inhibitor type-I protein potentially facilitating the stabilization of atherosclerotic plaques.
French CJ; Zaman AK; Sobel BE
J Cardiovasc Pharmacol; 2011 Aug; 58(2):143-8. PubMed ID: 21558880
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.
Chen Y; Kelm RJ; Budd RC; Sobel BE; Schneider DJ
J Cell Biochem; 2004 May; 92(1):178-88. PubMed ID: 15095413
[TBL] [Abstract][Full Text] [Related]
5. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
[TBL] [Abstract][Full Text] [Related]
6. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
7. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
Clough MH; Schneider DJ; Sobel BE; White MF; Wadsworth MP; Taatjes DJ
J Histochem Cytochem; 2005 May; 53(5):603-10. PubMed ID: 15872053
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
Schober A; Knarren S; Lietz M; Lin EA; Weber C
Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
Sukhova GK; Wang B; Libby P; Pan JH; Zhang Y; Grubb A; Fang K; Chapman HA; Shi GP
Circ Res; 2005 Feb; 96(3):368-75. PubMed ID: 15653570
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.
Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412
[TBL] [Abstract][Full Text] [Related]
15. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis.
Feil S; Hofmann F; Feil R
Circ Res; 2004 Apr; 94(7):863-5. PubMed ID: 15044321
[TBL] [Abstract][Full Text] [Related]
16. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
[TBL] [Abstract][Full Text] [Related]
18. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
19. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
Sanz-González SM; Barquín L; García-Cao I; Roque M; González JM; Fuster JJ; Castells MT; Flores JM; Serrano M; Andrés V
Cardiovasc Res; 2007 Sep; 75(4):803-12. PubMed ID: 17570351
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
Shimano H; Ohsuga J; Shimada M; Namba Y; Gotoda T; Harada K; Katsuki M; Yazaki Y; Yamada N
J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]